financetom
Business
financetom
/
Business
/
Seelos says ALS treatment fails in mid-stage study
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Seelos says ALS treatment fails in mid-stage study
Mar 19, 2024 5:36 AM

March 19 (Reuters) - Seelos Therapeutics ( SEEL ) said

on Tuesday that its treatment for a neurological disorder called

ALS, or amyotrophic lateral sclerosis, failed to meet the main

goal of a mid-stage trial.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Fortune Minerals' Option to Acquire Alberta Industrial Site for NICO Project Expires
Update: Fortune Minerals' Option to Acquire Alberta Industrial Site for NICO Project Expires
Jul 2, 2024
11:59 AM EDT, 07/02/2024 (MT Newswires) -- Fortune Minerals ( FTMDF ) over the holiday weekend said an option to purchase the JFSL Field Services ULC brownfield industrial site in Alberta for the NICO cobalt-gold-bismuth-copper project expired. The company could not complete the acquisition of the site in Lamont County before the June 30 expiry date. However, Fortune and JFSL...
Why Azitra (AZTR) Shares Are Down 29% Today
Why Azitra (AZTR) Shares Are Down 29% Today
Jul 2, 2024
Azitra Inc ( AZTR ) shares are trading lower by 29% to $2.41 during Tuesday’s session after the company announced a mixed shelf offering of up to $50 million. The company says these securities can be sold directly, through agents or via underwriters and dealers. Additionally, up to 217,082 shares of common stock, including 211,470 shares and 5,612 shares from warrant...
What's Going On With GameStop Stock Tuesday?
What's Going On With GameStop Stock Tuesday?
Jul 2, 2024
GameStop Corp ( GME ) shares are trading narrowly higher on low volume as retail traders continue to speculate about recent moves from meme stock trader Keith Gill, also known as “Roaring Kitty.” What To Know: Gill is responsible for much of the recent volatility in GameStop ( GME ) and other retail darlings as he made a return to...
Topaz Energy's Price Target Raised to $28.50, Outperform Rating Maintained, by National Bank of Canada
Topaz Energy's Price Target Raised to $28.50, Outperform Rating Maintained, by National Bank of Canada
Jul 2, 2024
11:45 AM EDT, 07/02/2024 (MT Newswires) -- National Bank of Canada on Tuesday raised its price target on the shares of Topaz Energy ( TPZEF ) 's price target to $28.50 from $27.50 while maintaining its outperform after the company announced a $100 million infrastructure acquisition from Whitecap Resources (WCP.TO). The deal includes a 50% stake in 20,000 barrels of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved